https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT05060016&r=1
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
phasestudytarlatamabpatientssmall
https://www.tarlatamabclinicaltrials.com/en
Learn how Amgen Oncology is testing the drug tarlatamab to see how safe and effective it is at treating patients who have small-cell lung cancer (SCLC).
clinical trialsamgentarlatamab